India Biosimilars Market (2024-2030) Outlook | Value, Analysis, Revenue, Share, Forecast, Companies, Industry, Size, Growth & Trends

Market Forecast By Product (Insulin, Follitropin, Calcitonin, Glucagon, Teriparatide, Others), By Indication (Oncology, Offsite Treatment, Chronic Disorders, Blood Disorders, Infectious Diseases, Others), By Manufacturing (Outsourced, In-house) And Competitive Landscape
Product Code: ETC069943 Publication Date: Jun 2023 Updated Date: Jan 2024 Product Type: Report
Publisher: 6Wresearch No. of Pages: 70 No. of Figures: 35 No. of Tables: 5

India Biosimilars Market Synopsis

The India biosimilar market is expected to grow at a CAGR of 24.5% during the forecast period from 2020 to 2027, due to increasing government support and initiatives such as Make in India program and Drug Pricing Control Order (DPCO). This has enabled increased access for drugs at low cost and improved affordability among consumers across the country. The rising prevalence of chronic diseases such as cancer, diabetes, rheumatoid arthritis and others are driving growth in the market. Additionally, technological advancements related to biologics development have facilitated greater acceptance among medical professionals for using biosimilars instead of branded products or generic medicines.

Drivers of the Market:

Increasing Prevalence Of Chronic Diseases: The rising prevalence of chronic conditions is fueling demand for more effective treatment solutions, which is boosting the adoption rate of biological therapies including monoclonal antibody-based therapeutics (mAb), recombinant proteins/antibodies (rPAb), peptides/small molecules etc., thereby providing an impetus for growth in this sector. Government Incentives And Regulatory Support: Various government schemes like Pradhan Mantri Jan Aushadhi Yojana (PMJAY) have been launched to provide affordable healthcare services by enabling access to quality medicines at lower prices through public distribution systems such as Jan Aushadi stores ? these also include various kinds of biologicals including biosimilars. Additionally, regulatory authorities like Central Drugs Standard Control Organization (CDSCO) have introduced certain guidelines that help simplify product registration processes while promoting innovation within this space so that manufacturers can make high-quality yet cost-effective products available in the market without compromising safety standards or efficacy parameters.

Key Highlights of the Report:

  • India Biosimilars Market Outlook
  • Market Size of India Biosimilars Market, 2020
  • Forecast of India Biosimilars Market, 2027
  • Historical Data and Forecast of India Biosimilars Revenues & Volume for the Period 2023 - 2027
  • India Biosimilars Market Trend Evolution
  • India Biosimilars Market Drivers and Challenges
  • India Biosimilars Price Trends
  • India Biosimilars Porter's Five Forces
  • India Biosimilars Industry Life Cycle
  • Historical Data and Forecast of India Biosimilars Market Revenues & Volume By Product for the Period 2023 - 2027
  • Historical Data and Forecast of India Biosimilars Market Revenues & Volume By Insulin for the Period 2023 - 2027
  • Historical Data and Forecast of India Biosimilars Market Revenues & Volume By Follitropin for the Period 2023 - 2027
  • Historical Data and Forecast of India Biosimilars Market Revenues & Volume By Calcitonin for the Period 2023 - 2027
  • Historical Data and Forecast of India Biosimilars Market Revenues & Volume By Glucagon for the Period 2023 - 2027
  • Historical Data and Forecast of India Biosimilars Market Revenues & Volume By Teriparatide for the Period 2023 - 2027
  • Historical Data and Forecast of India Biosimilars Market Revenues & Volume By Others for the Period 2023 - 2027
  • Historical Data and Forecast of India Biosimilars Market Revenues & Volume By Indication for the Period 2023 - 2027
  • Historical Data and Forecast of India Biosimilars Market Revenues & Volume By Oncology for the Period 2023 - 2027
  • Historical Data and Forecast of India Biosimilars Market Revenues & Volume By Offsite Treatment for the Period 2023 - 2027
  • Historical Data and Forecast of India Biosimilars Market Revenues & Volume By Chronic Disorders for the Period 2023 - 2027
  • Historical Data and Forecast of India Biosimilars Market Revenues & Volume By Blood Disorders for the Period 2023 - 2027
  • Historical Data and Forecast of India Biosimilars Market Revenues & Volume By Infectious Diseases for the Period 2023 - 2027
  • Historical Data and Forecast of India Biosimilars Market Revenues & Volume By Others for the Period 2023 - 2027
  • Historical Data and Forecast of India Biosimilars Market Revenues & Volume By Manufacturing for the Period 2023 - 2027
  • Historical Data and Forecast of India Biosimilars Market Revenues & Volume By Outsourced for the Period 2023 - 2027
  • Historical Data and Forecast of India Biosimilars Market Revenues & Volume By In-house for the Period 2023 - 2027
  • India Biosimilars Import Export Trade Statistics
  • Market Opportunity Assessment By Product
  • Market Opportunity Assessment By Indication
  • Market Opportunity Assessment By Manufacturing
  • India Biosimilars Top Companies Market Share
  • India Biosimilars Competitive Benchmarking By Technical and Operational Parameters
  • India Biosimilars Company Profiles
  • India Biosimilars Key Strategic Recommendations
Frequently Asked Questions About the Market Study (FAQs):
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 India Biosimilars Market Overview

3.1 India Country Macro Economic Indicators

3.2 India Biosimilars Market Revenues & Volume, 2020 & 2027F

3.3 India Biosimilars Market - Industry Life Cycle

3.4 India Biosimilars Market - Porter's Five Forces

3.5 India Biosimilars Market Revenues & Volume Share, By Product, 2020 & 2027F

3.6 India Biosimilars Market Revenues & Volume Share, By Indication, 2020 & 2027F

3.7 India Biosimilars Market Revenues & Volume Share, By Manufacturing, 2020 & 2027F

4 India Biosimilars Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.3 Market Restraints

5 India Biosimilars Market Trends

6 India Biosimilars Market, By Types

6.1 India Biosimilars Market, By Product

6.1.1 Overview and Analysis

6.1.2 India Biosimilars Market Revenues & Volume, By Product, 2018 - 2027F

6.1.3 India Biosimilars Market Revenues & Volume, By Insulin, 2018 - 2027F

6.1.4 India Biosimilars Market Revenues & Volume, By Follitropin, 2018 - 2027F

6.1.5 India Biosimilars Market Revenues & Volume, By Calcitonin, 2018 - 2027F

6.1.6 India Biosimilars Market Revenues & Volume, By Glucagon, 2018 - 2027F

6.1.7 India Biosimilars Market Revenues & Volume, By Teriparatide, 2018 - 2027F

6.1.8 India Biosimilars Market Revenues & Volume, By Others, 2018 - 2027F

6.2 India Biosimilars Market, By Indication

6.2.1 Overview and Analysis

6.2.2 India Biosimilars Market Revenues & Volume, By Oncology, 2018 - 2027F

6.2.3 India Biosimilars Market Revenues & Volume, By Offsite Treatment, 2018 - 2027F

6.2.4 India Biosimilars Market Revenues & Volume, By Chronic Disorders, 2018 - 2027F

6.2.5 India Biosimilars Market Revenues & Volume, By Blood Disorders, 2018 - 2027F

6.2.6 India Biosimilars Market Revenues & Volume, By Infectious Diseases, 2018 - 2027F

6.2.7 India Biosimilars Market Revenues & Volume, By Others, 2018 - 2027F

6.3 India Biosimilars Market, By Manufacturing

6.3.1 Overview and Analysis

6.3.2 India Biosimilars Market Revenues & Volume, By Outsourced, 2018 - 2027F

6.3.3 India Biosimilars Market Revenues & Volume, By In-house, 2018 - 2027F

7 India Biosimilars Market Import-Export Trade Statistics

7.1 India Biosimilars Market Export to Major Countries

7.2 India Biosimilars Market Imports from Major Countries

8 India Biosimilars Market Key Performance Indicators

9 India Biosimilars Market - Opportunity Assessment

9.1 India Biosimilars Market Opportunity Assessment, By Product, 2020 & 2027F

9.2 India Biosimilars Market Opportunity Assessment, By Indication, 2020 & 2027F

9.3 India Biosimilars Market Opportunity Assessment, By Manufacturing, 2020 & 2027F

10 India Biosimilars Market - Competitive Landscape

10.1 India Biosimilars Market Revenue Share, By Companies, 2020

10.2 India Biosimilars Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Related Reports

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All